Recent progress in advanced glycation end products and diabetic complications.
Vlassara
H
H
Picower Institute for Medical Research, Manhasset, New York 11030, USA.
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology* / Q000473:pathology; D003920:Diabetes Mellitus / Q000378:metabolism*; D003925:Diabetic Angiopathies / Q000378:metabolism*; D017127:Glycation End Products, Advanced / Q000378:metabolism*; D006801:Humans; D050356:Lipid Metabolism; D008264:Macrophages / Q000502:physiology; D009569:Nitric Oxide / Q000502:physiology; D011506:Proteins / Q000378:metabolism; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic / Q000378:metabolism*
D017127:Glycation End Products, Advanced; D011506:Proteins; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic; D009569:Nitric Oxide